Cargando…

Long-Term Outcomes of Donor Site Morbidity After Sural Nerve Graft Harvesting

PURPOSE: Although nerve autografts have been considered the standard treatment for peripheral nerve defects, limited studies have reported long-term outcomes of nerve harvesting over 15 years after surgery. This study aimed to evaluate the long-term outcomes of donor site morbidity after sural nerve...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Kaoru, Nakada, Mika, Matsuta, Masashi, Yamauchi, Daisuke, Ikeda, Kazuo, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991447/
https://www.ncbi.nlm.nih.gov/pubmed/35415478
http://dx.doi.org/10.1016/j.jhsg.2020.01.001
Descripción
Sumario:PURPOSE: Although nerve autografts have been considered the standard treatment for peripheral nerve defects, limited studies have reported long-term outcomes of nerve harvesting over 15 years after surgery. This study aimed to evaluate the long-term outcomes of donor site morbidity after sural nerve graft harvesting. METHODS: Thirteen patients for whom more than 15 years had passed after harvesting of the sural nerve for peripheral nerve defects were included. Mean follow-up was 29.5 years. Sensory disturbances and difficulty in performing foot movements immediately after surgery and currently were evaluated on a 10-point scale. Influences on daily living and work and current satisfaction with the autologous sural nerve graft were evaluated. RESULTS: Sensory disturbances and difficulty in movement tended to improve; however, the differences between time points were not significant. Influences on activities of daily living and work were mild, and the satisfaction level for autologous sural nerve graft was high. CONCLUSIONS: Although donor site morbidity after sural nerve graft harvesting persisted for a long time after surgery, foot symptoms and functional impairment were mild. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic V.